** Shares in German medical technology company Siemens Healthineers SHLG.DE rise 2% after Q3 results beat consensus expectations and the company raised its guidance
** Revenues beat by 1%. adj. EBIT by 7.9% and adj. EPS by 20.8%, with FY revenue guidance narrowed to the top half of the range and EPS guidance narrowed with a higher mid-point
** J.P.Morgan says "ordinarily we would expect a rally in the shares (MSD+), but this may fade given the perceived overhang of the parent stake"
** Jefferies says a 6% y/y sales growth in China could pave the way for more optimism in FY 2025 into 2026 but "expect caution to prevail given uncertainty about the timing/magnitude of the recovery"
** Shares outperform the DAX .GDAXI index, which falls 0.2%
(Reporting by Bernadette Hogg)
((bernadette.hogg@thomsonreuters.com))